Cargando…
BH3-mimetics: recent developments in cancer therapy
The hopeful outcomes from 30 years of research in BH3-mimetics have indeed served a number of solid paradigms for targeting intermediates from the apoptosis pathway in a variety of diseased states. Not only have such rational approaches in drug design yielded several key therapeutics, such outputs h...
Autores principales: | Townsend, Paul A., Kozhevnikova, Maria V., Cexus, Olivier N. F., Zamyatnin, Andrey A., Soond, Surinder M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576916/ https://www.ncbi.nlm.nih.gov/pubmed/34753495 http://dx.doi.org/10.1186/s13046-021-02157-5 |
Ejemplares similares
-
Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer
por: Soond, Surinder M., et al.
Publicado: (2019) -
Integrative p53, micro-RNA and Cathepsin Protease Co-Regulatory Expression Networks in Cancer
por: Soond, Surinder M., et al.
Publicado: (2020) -
Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2021) -
Helicobacter pylori and gastric cancer: a lysosomal protease perspective
por: Soond, Surinder M., et al.
Publicado: (2021) -
Harnessing the Potential of Killers and Altruists within the Microbial Community: A Possible Alternative to Antibiotic Therapy?
por: Ikryannikova, Larisa N., et al.
Publicado: (2019)